NCT02734810 - SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions

Exocrine Pancreatic InsufficiencyCystic Fibrosis

Interventions

DRUG

Liprotamase Powder for Oral Solution

Oral, soluble, non-enterically coated, non-porcine, pancreatic enzyme replacement therapy

Trial Locations (21)

17033

Investigator Site 106, Hershey

23298

Investigator Site 112, Richmond

26506

Investigator Site 129, Morgantown

27710

Investigator Site 118, Durham

30342

Investigator Site 110, Atlanta

32701

Investigator Site 117, Altamonte Springs

33021

Investigator Site 138, Hollywood

33136

Investigator Site 130, Miami

40202

Investigator Site 122, Louisville

60025

Investigator Site 109, Glenview

67214

Investigator Site 105, Wichita

72202

Investigator Site 139, Little Rock

73104

Investigator Site 101, Oklahoma City

73112

Investigator Site 136, Oklahoma City

77030

Investigator Site 116, Houston

80045

Investigator Site 114, Aurora

89107

Investigator Site 135, Las Vegas

92868

Investigator Site, Orange

04102

Investigator Site 132, Portland

48109-5212

Investigator Site 124, Ann Arbor

75390-9063

Investigator Site 111, Dallas